Genetics. In the article, "A member of a family of sulfateactivating enzymes causes murine brachymorphism," by Kiyoto Kurima, Matthew L. Warman, Srinivasan Krishnan, Miriam Domowicz, Richard C. Krueger, Jr., Andrea Deyrup, and Nancy B. Schwartz, which appeared in number 15, July 21, 1998, of Proc. Natl. Acad. Sci. USA (95, 8681-8685), the following correction should be noted. An early version of Fig. 2 containing several errors was printed. The corrected figure and its legend are reproduced below. This version contains sequence data identical to that which was deposited in the GenBank database (accession no. AF052453) on March 4, 1998. Sulfation is a necessary modification of proteins, carbohydrates, and lipids. One of the most prominent roles of sulfation in vertebrates is the posttranslational modification of glycosaminoglycans, the repeating disaccharide chains that are covalently linked to protein cores to constitute the family of proteoglycans. Sulfation requires active transport of sulfate into the cell, conversion into the ''active'' high energy form of phosphoadenosine-phosphosulfate (PAPS), translocation of PAPS across the golgi membrane, and transfer of sulfate from PAPS, via a multitude of sulfotransferases, to the recipient biomolecules (1) . The sulfate activation pathway consists of two activities, ATP-sulfurylase (EC 2.7.7.4), which catalyzes synthesis of adenosine-phosphosulfate (APS) from ATP and SO 4 Ϫ2 , and APS kinase (EC 2.7.1.25), which phosphorylates APS in the presence of another molecule of ATP to form PAPS. In simpler organisms these activities are catalyzed by separate enzymes (2) (3) (4) (5) . In contrast, when these two sulfateactivating activities were purified from rat chondrosarcoma they were found to exist as a bifunctional enzyme (6, 7), which uses a channeling mechanism to transfer the intermediate APS efficiently from the sulfurylase to the kinase active site (8) (9) (10) . Subsequently, a mouse cDNA encoding a fused ATPsulfurylase͞APS kinase was isolated. This mammalian PAPS synthetase (referred to as SK1) is a bifunctional polypeptide that catalyzes both ATP-sulfurylase and APS-kinase reactions (11) .
Murine brachymorphism is characterized by dome-shaped skull, short thick tail, and shortened but not widened limbs (12, 13) and has been attributed to a defective PAPS synthesis pathway (14) (15) (16) (17) . The phenotype is inherited as an autosomal recessive, and bm homozygotes breed normally, have life spans comparable to wild-type mice, and are about the same size as normals at birth. The difference in size becomes apparent over the first 4 weeks of life, resulting in a 50% reduction in limb length and a 25% reduction in axial skeletal size (Fig. 1) . The effect on growth is concomitant with a progressive reduction in size of the columnar and hypertrophic zones in the epiphyseal growth plates. Histological and ultrastructual studies suggest a defective cartilage matrix that contains normal collagen fibrils, but proteoglycan aggregate granules that are smaller than normal and present in reduced numbers, particularly in the growth plate (18) . Biochemical analysis showed that brachymorphic cartilage contains normal levels of glycosaminoglycans but with disaccharides that are significantly undersulfated. The reduced incorporation of sulfate in brachymorphic cartilage is associated with limited PAPS availability because of a reduction predominantly in APS-kinase activity (14) (15) (16) (17) . Genetic linkage studies localized the bm gene on chromosome 19 (12, 19) . However, the precise gene responsible for brachymorphism has not been identified.
Here we report the isolation of an additional member of the PAPS synthetase family, SK2, and the chromosomal localization of both SK1 and SK2 genes. SK2 is mapped on chromosome 19 and is tightly linked with the marker for bm locus (19) . Sequence analysis of a bm SK2 cDNA revealed a missense mutation that results in a glycine-to-arginine substitution at a highly conserved portion of the APS-kinase domain, and bacterially expressed bm SK2 fails to catalyze the APS-kinase reaction and to synthesize PAPS. These findings indicate that the mutation in the SK2 gene is responsible for murine brachymorphism.
MATERIALS AND METHODS
Identification and Cloning of SK2. The deduced amino acid sequence of SK1 (GenBank accession no. U34883) was used as a BLAST query sequence against the expressed sequence tag (EST) database maintained by the National Center for Biotechnology Information at the National Library of Medicine. Nucleotide sequences from several EST clones suspected to contain SK2 cDNA initially were used to generate oligonucleotide primers. The 5Ј-end of a cDNA sequence subsequently was obtained by the 5Ј-inverse PCR method (20) . Reverse
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transcription-PCR (RT-PCR) was performed on total RNA extracted from normal and bm neonatal livers. The first strand was synthesized by SuperScript II (GIBCO͞BRL) using an antisense primer (SK5, 5Ј-GCAATTGGATACAGAG-CAGC-3Ј) complementary to the 3Ј-untranslated region of SK2 mRNA. The complete ORF cDNA was amplified with a 5Ј-end sense primer containing a NdeI site (SK30, 5Ј-AGAGAGT TCCATATGTCTGCA A AT TCCA A A ATG-AACCATAAAAGAGACCAGC-3Ј) and a 3Ј-end antisense primer containing a XhoI site (SK31, 5Ј-GAGAGAGATCTC-GAGCTAGT TGGTCT TCTCCAGAGACCTGTAGTA-ATCTGTCAACAC-3Ј) using Expand (Boehringer-Mannheim). RT-PCR of the total liver RNA yielded a single band approximately 1.9 kb in length. The fragment was digested with NdeI and XhoI and cloned into appropriate restriction sites in a bacterial expression vector, pET-15b (Novagen). The nucleotide sequence was determined by the dideoxynucleotide chain termination method using T7 sequenase kit (Amersham). To confirm the bm SK2 mutation at nucleotide 235, genomic DNA sequence at the nucleotide 235 site from the normal and bm mice was determined after amplifying genomic DNA fragments by PCR using a set of two primers flanking the mutation site (SK15, 5Ј-CAGTAGATCTCGAGTGCGGATAT-TCTCTTCTCGGTCC-3Ј; SK26, 5Ј-CAACAATAAGCTT-TCCTTTGGAAGAGTACC-3Ј).
Northern Blot Analysis. Livers were dissected from neonatal normal and bm mice and immediately frozen on dry ice, and total RNA was isolated by using TRIzol (GIBCO͞BRL). Fifteen micrograms of total liver RNA was electrophoresed in a 1% agarose-formaldehyde gel and transferred to a Nytran filter. Prehybridization, hybridization with the 32 P-labeled 1.9-kb SK2 cDNA, and washing were performed as previously described (11) . The same filter was stripped and rehybridized with a mouse ␤-actin cDNA probe.
Recombinant Enzyme Assays. An Escherichia coli strain, BL21(DE3), was transformed by the heat-shock method with a SK2 cDNA cloned in pET-15b vector (Novagen). Isopropyl ␤-D-thiogalactoside (10 mM) was added to an overnight bacterial culture and incubated for an additional 4 hr. The bacterial cell cultures were centrifuged at 9,000 ϫ g, and the pellet was resuspended into IMAC 5 buffer (5 mM imidazole͞50 mM Tris, pH 7.9). The protein was purified after cell sonication and gravity His-tag purification (Novagen) and quantitated by the Pierce BCA protein assay method. Purified enzyme was dialysed into phosphate buffer (25 mM NaH 2 PO 4 -K 2 HPO 4 , pH 7.8͞1 mM DTT͞1 mM EDTA) overnight and diluted with phosphate buffer to 20 g͞ml for enzymatic assays. Crude extracts from bacteria carrying the vector without insert and no vector were used as negative controls. The ATP-sulfurylase was assayed in the reverse direction of ATP formation as described (8) . Standard ATP-sulfurylase assays contained 50 mM NaH 2 PO 4 -K 2 HPO 4 (pH 7.8), 12 mM MgCl 2 , 0.5 mM DTT, 5 mM NaF, 0.2 mM Na 4 P 2 O 7 (containing 6.7 mCi of 32 P), 0.1 mM APS, and 50 l of enzyme preparation. APS kinase was assayed as described (10) . Standard APSkinase assay contained 80 nM [ 35 S]APS, 0.5 mM ATP (pH 7.0), 5 mM MgCl 2 , 10 mM ammonium sulfate, and 12 l of enzyme, brought up to 25 l with buffer A (25 mM NaH 2 PO 4 -K 2 HPO 4 , pH 7.8͞1 mM DTT͞1 mM EDTA͞10% glycerol). The overall reaction with ATP and SO 4 2Ϫ as substrates and measuring the production of APS and PAPS was assayed as described (6) . Chromosomal Localization. A murine SK1 PCR product from primer pair SK16 (5Ј-GGA A ACGGCCTGAT T-TCAGG-3Ј) and SK21 (5Ј-CACGCGAAGGCCAGAAACC-3Ј) was used to amplify a 190-bp intragenic SK1 fragment from C57BL͞6J and Mus spretus genomic DNA. The resulting amplimers were separated on a nondenaturing 0.5ϫ mutation detection enhancement (MDE) (FMC) gel at 6 W for 20 hr. Amplimers were visualized by autoradiography because the SK16 primer had been end-labeled with 32 P before PCR amplification. A single-strand conformational polymorphism (SSCP) (21) was detected between C57BL͞6J and M. spretus; this SSCP then was evaluated on the BSS backcross mapping panel available from the Jackson Laboratory (22) . Offspring were scored as homozygous for the spretus allele or heterozygous for C57BL͞6J and spretus alleles. Results were submitted to the Jackson Laboratory, where precise mapping was determined relative to previously tested markers. Murine SK2 was mapped by using the same approach, but with the murine SK2-specific primer pair SK12 (5Ј-GGAGAAAACCAACTAGGTGCTCCTGGC-3Ј) and SK13 (5Ј-CATAGTGGCTGAGATGAAGTGTACAGTGC-3Ј). This pair amplifies a 287-bp intragenic fragment of the SK2 gene, which also has a single-strand conformational polymorphism between C57BL͞6J and M. spretus. Offspring of the BSS backcross were scored for this SK2 polymorphism and results were submitted to the Jackson Laboratory. SK2 was found to cosegregate with D19Mit13 (logarithm of odds 28.3 at ϭ 0) The human SK genes were placed on the genetic map via radiation hybrid mapping (23) .
RESULTS
Cloning and Characterization of a SK2 cDNA. The earlier cloning of the bifunctional murine SK (SK1) (11) did not identify the underlying etiology of the brachymorphic phenotype. Furthermore, we genetically mapped SK1 to mouse chromosome 3, which is also incompatible with it being the cause of brachymorphism, which maps to chromosome 19 (12) . These results led us to consider the possibility that more than one SK gene might be present in mice. A second SK isoform first was detected after sequence similarity searching (24, 25) using murine SK1 as the query sequence. Two groups of murine ESTs were identified; one group having near identity to the query sequence and presumably representing SK1 transcripts. The other group of ESTs had lower nucleotide homology, but high amino acid identity, and potentially represents novel SK isoforms. One of these latter ESTs was used to isolate the complete cDNA of an additional isoform, Genetics: Kurima et al.
Proc. Natl. Acad. Sci. USA 95 (1998) referred to as SK2, from mouse total liver RNA by 5Ј-inverse PCR (20) (Fig. 2) . SK2 contains an uninterrupted coding sequence of 1,863 bp and has 76% identity at the amino acid level to SK1. SK2 also contains functional motifs previously associated with unifunctional ATP sulfurylases and APS kinases (11) . Northern blot analysis reveals a single SK2 transcript of 3.7 kb in normal and brachymorphic liver (Fig. 3) , slightly larger than the 3.3-kb SK1 transcript (11). The 3.7-kb SK2 transcript also was detected in cartilage, skin, and brain (data not shown). Chromosomal Localization of SK1 and SK2 Genes. SK1 was found to cosegregate with D3Xrf10, a locus on the distal end of chromosome 3 (logarithm of odds 28.3 at ϭ 0), whereas SK2 was mapped to chromosome 19 by using an intragenic single-strand conformational polymorphism on an interspecific backcross mapping panel. SK2 is tightly linked to D19Mit13, as is the bm locus (19) . Consequently, SK2 was tested as a candidate for causing brachymorphism.
Mutation Analysis and Recombinant SK2 Enzyme Assays. Sequence analysis of wild-type and bm SK2 cDNA revealed a single nucleotide change, a G to A transition, in the bm allele that changes a glycine residue to an arginine residue (Gly 79 to Arg) in the APS-kinase domain of the bifunctional enzyme (Fig. 2) . This change also is present in genomic DNA (Fig. 4) . That the change causes disease is suggested by the conservation of this glycine residue in all previously characterized bifunctional SK proteins and in all unifunctional APS kinases (11) . Further support for this mutation being the cause of the brachymorphic phenotype derives from in vitro assays of wild-type and mutant recombinant enzyme activities. Bacterially expressed recombinant SK2 protein was found to catalyze both ATP-sulfurylase and APS-kinase reactions, synthesizing PAPS comparably to SK1 (11) . In contrast to recombinant expressed wild-type SK2, recombinant expressed SK2 protein containing the Gly 79 to Arg mutation has no APSkinase activity, although its ATP-sulfurylase activity is maintained (Fig. 5) . Taken together these results indicate that this mutation is responsible for murine brachymorphism.
DISCUSSION
The activation of sulfate to produce the universal sulfate donor, PAPS, is critical to many processes, including the activation of numerous peptide and steroid hormones, the metabolism of catecholamines, the production of ceramide during brain development, the synthesis of sulfolipids in the reproductive system, the proper functioning of the blood coagulation cascade, the detoxification of endogenous compounds, and the modification of a variety of drugs, mutagens, and bile acids. Our results indicate a gene family is responsible for encoding this critical function and suggest nonredundant, tissue-specific role of each isoform, as demonstrated by the tissue-specific defect in PAPS synthesis in bm mice. Although the key steps in sulfating biomolecules have been assumed to be at the level of the myriad of sulfotransferases, our findings further demonstrate that regulation at the level of forming the sulfate donor is important as well, suggesting possible regulatory mechanisms at other steps along the overall sulfation pathway. Finally, the finding of additional ESTs (unpublished data), which have reduced nucleotide identity but high amino acid identity to SK1 and SK2, suggests that this family will likely grow.
It is intriguing that the SK2 mutation specifically affects postnatal skeletal development and other selected tissues. Newborn bm mice appear skeletally normal, suggesting that the SK2 gene product's principal role during skeletogenesis is during postnatal growth and that other SKs may substitute for SK2 in utero. It has been shown that hepatic detoxification in bm mice is principally via glucuronidation, whereas it is via sulfation in wild-type mice (26) . Bleeding times are also abnormal in bm mice (19) . However, other tissues that contain important sulfated biomolecules such as the kidney and brain appear normal in bm mice, suggesting tissue-specific sulfation mechanisms (17) . Although the SK2 transcript is found in total brain RNA, bm mice do not have an obvious neurologic phenotype. Careful neurological testing of bm homozygotes now is indicated to determine whether there may be subtle neurological effects, although absence of such a phenotype simply may represent functional redundancy for sulfate activation in the brain or a minor role for SK2 in this tissue. The contribution of each SK isoform during growth and development must await the identification of all family members and careful quantitation of their mRNA and protein levels. However, because it is now clear that the PAPS synthetases constitute a gene family, with known members lacking complete functional redundancy at the tissue level and with perhaps more members yet to be discovered, the bm mouse is an excellent model to study the role of sulfation in a variety of specific processes.
There are not yet human counterparts for the bm or other SK mutant phenotypes. Radiation hybrid mapping of the (1998) human homologues of SK1 and SK2 place them on chromosomes 4q and 10q, respectively (unpublished data), consistent with the locations of other human genes whose mouse homologues are syntenic with the SK loci. At present no likely murine phenotype colocalizes with the SK1 locus, nor have likely human phenotypes been mapped to regions containing the human SK homologues. However, human genetic disorders have been associated with mutations in other components of the sulfate metabolic pathway; for example, mutations at the locus encoding the high affinity sulfate transporter (DTDST), responsible for uptake of inorganic sulfate (one of the two substrates for SKs) into the cell, are associated with skeletal phenotypes also having undersulfated proteoglycans (27) (28) (29) . Consequently, one would predict that mutations in SK1 and SK2 also will have consequences in humans.
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